BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1339480)

  • 1. Prediction of homologous binding sites on RB and p107 common for viral oncoproteins and cellular ligands.
    Wendtner CM; Radulescu RT
    J Mol Recognit; 1992 Dec; 5(4):125-32. PubMed ID: 1339480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product.
    Huang S; Lee WH; Lee EY
    Nature; 1991 Mar; 350(6314):160-2. PubMed ID: 2005966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding.
    Fan S; Yuan R; Ma YX; Xiong J; Meng Q; Erdos M; Zhao JN; Goldberg ID; Pestell RG; Rosen EM
    Oncogene; 2001 Aug; 20(35):4827-41. PubMed ID: 11521194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression.
    Sterner JM; Tao Y; Kennett SB; Kim HG; Horowitz JM
    Cell Growth Differ; 1996 Jan; 7(1):53-64. PubMed ID: 8788033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed interaction between insulin and retinoblastoma protein.
    Radulescu RT; Wendtner CM
    J Mol Recognit; 1992 Dec; 5(4):132-7. PubMed ID: 1339481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts.
    Liu SL; Rand A; Kelm RJ; Getz MJ
    Oncogene; 2000 Jul; 19(30):3352-62. PubMed ID: 10918592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new component of the transcription factor DRTF1/E2F.
    Girling R; Partridge JF; Bandara LR; Burden N; Totty NF; Hsuan JJ; La Thangue NB
    Nature; 1993 Mar; 362(6415):83-7. PubMed ID: 8446173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Converting the JCV T antigen Rb binding domain to that of SV40 does not alter JCV's limited transforming activity but does eliminate viral viability.
    Tavis JE; Trowbridge PW; Frisque RJ
    Virology; 1994 Mar; 199(2):384-92. PubMed ID: 8122368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of cancer suppression by the retinoblastoma gene.
    Lee WH
    Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The two nonstructural proteins from wheat dwarf virus involved in viral gene expression and replication are retinoblastoma-binding proteins.
    Collin S; Fernández-Lobato M; Gooding PS; Mullineaux PM; Fenoll C
    Virology; 1996 May; 219(1):324-9. PubMed ID: 8623550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
    Ledl A; Schmidt D; Müller S
    Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexes containing the retinoblastoma gene product recognize different DNA motifs related to the E2F binding site.
    Ouellette MM; Chen J; Wright WE; Shay JW
    Oncogene; 1992 Jun; 7(6):1075-81. PubMed ID: 1534398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.
    Cao L; Faha B; Dembski M; Tsai LH; Harlow E; Dyson N
    Nature; 1992 Jan; 355(6356):176-9. PubMed ID: 1530885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7.
    Lee JO; Russo AA; Pavletich NP
    Nature; 1998 Feb; 391(6670):859-65. PubMed ID: 9495340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The retinoblastoma binding factor 1 (RBF-1) site in RB gene promoter binds preferentially E4TF1, a member of the Ets transcription factors family.
    Savoysky E; Mizuno T; Sowa Y; Watanabe H; Sawada J; Nomura H; Ohsugi Y; Handa H; Sakai T
    Oncogene; 1994 Jul; 9(7):1839-46. PubMed ID: 8208529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 contains a DNA break-binding motif similar to the functional part of BRCT-related region of Rb.
    Yamane K; Katayama E; Tsuruo T
    Oncogene; 2001 May; 20(23):2859-67. PubMed ID: 11420698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein.
    Hall FL; Williams RT; Wu L; Wu F; Carbonaro-Hall DA; Harper JW; Warburton D
    Oncogene; 1993 May; 8(5):1377-84. PubMed ID: 8479754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
    Pan W; Cox S; Hoess RH; Grafström RH
    Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells.
    Vooijs M; te Riele H; van der Valk M; Berns A
    Oncogene; 2002 Jul; 21(30):4635-45. PubMed ID: 12096340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoblastoma susceptibility protein, Rb, possesses multiple BRCT-Ws, BRCA1 carboxyl-terminus-related W regions with DNA break-binding activity.
    Yamane K; Katayama E; Sugasawa K; Tsuruo T
    Oncogene; 2000 Apr; 19(16):1982-91. PubMed ID: 10803459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.